A Study of LY2484595 on Pharmacokinetics in Healthy Participants
PHASE1
This is a 2-part study. Part 1 is to determine the safety and tolerability ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers
PHASE1
To investigate whether and to what extent the P-glycoprotein (P-gp) inhibit...
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C
PHASE1
The purpose of this study is to determine multiple dose safety, tolerabilit...